68901-09-7 Usage
General Description
2-chloro-5-(methylsulphamoyl)benzoic acid is a chemical compound with the molecular formula C8H8ClNO4S. It is a derivative of benzoic acid and contains a chlorine atom and a methylsulphamoyl group attached to the benzene ring. 2-chloro-5-(methylsulphamoyl)benzoic acid is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also known for its potential antimicrobial and anti-inflammatory properties. Additionally, it has been studied for its ability to inhibit the enzyme carbonic anhydrase and has shown promising results in the treatment of certain diseases such as glaucoma and epilepsy.
Check Digit Verification of cas no
The CAS Registry Mumber 68901-09-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,9,0 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 68901-09:
(7*6)+(6*8)+(5*9)+(4*0)+(3*1)+(2*0)+(1*9)=147
147 % 10 = 7
So 68901-09-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H8ClNO4S/c1-10-15(13,14)5-2-3-7(9)6(4-5)8(11)12/h2-4,10H,1H3,(H,11,12)/p-1
68901-09-7Relevant articles and documents
Sulfanyl substituted phenyl methanones
-
Page/Page column 16, (2008/06/13)
The present invention relates to compounds of formula I wherein R1, R2, R3, X, X1, and n are as defined in the specification and pharmaceutically acceptable acid addition salts thereof. These compounds are good inhibitors of the glycine transporter 1 (GlyT-1) for the treatment CNS disorders, such as schizophrenia, cognitive impairment, and Alzheimer's disease.
1- (2-AMINO-BENZOL) -PIPERAZINE DERIVATIVES AS GLYCINE UPTAKE INHIBITORS FOR THE TREATMENT OF PSYCHOSES
-
Page/Page column 52, (2008/06/13)
A compound of formula (I) wherein the substituents are described in claim 1 for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.
